FDA approves ibrutinib for previously treated MCLNovember 14, 2013Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Phase 3 ponatinib trial stopped due to adverse eventsOctober 19, 2013Leukemia, Myelodysplasia, Transplantation
Drug gets orphan designation for MDSOctober 4, 2013AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome